Application 218312
- Type
- ANDA
- Sponsor
- BRIGHTGENE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FONDAPARINUX SODIUM | FONDAPARINUX SODIUM | SOLUTION;SUBCUTANEOUS | 2.5MG/0.5ML (2.5MG/0.5ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218312-001 | FONDAPARINUX SODIUM | FONDAPARINUX SODIUM | 2.5MG/0.5ML (2.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | 2024-12-18 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A218312-001 | FONDAPARINUX SODIUM | 2.5MG/0.5ML | SOLUTION / SUBCUTANEOUS | 2024-12-18 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218312-001 | FONDAPARINUX SODIUM | 2.5MG/0.5ML | INJECTABLE / SUBCUTANEOUS | 2024-12-18 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A218312-001 | FONDAPARINUX SODIUM | 2.5MG/0.5ML | INJECTABLE / SUBCUTANEOUS | AP | 2024-12-18 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218312-001 | FONDAPARINUX SODIUM | 2.5MG/0.5ML | INJECTABLE / SUBCUTANEOUS | AP | 2024-12-18 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218312-001 | FONDAPARINUX SODIUM | 2.5MG/0.5ML | INJECTABLE / SUBCUTANEOUS | AP | 2024-12-18 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218312-001 | FONDAPARINUX SODIUM | 2.5MG/0.5ML | INJECTABLE / SUBCUTANEOUS | AP | 2024-12-18 | 03ed91905a0d… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218312-001 | FONDAPARINUX SODIUM | 2.5MG/0.5ML (2.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | 2024-12-18 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-08-23 18:47 UTC | 2025-08 | A218312-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218312-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218312-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218312-001 | AP | 1 | 03ed91905a0d… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| fondaparinux sodium | FONDAPARINUX SODIUM | Zydus Pharmaceuticals (USA) Inc. | dffbf7c9-495e-4a33-ac76-57b52f014fc2 | 2025-10-28 | Boxed warning, Warnings, Adverse reactions | fondaparinux sodium FONDAPARINUX SODIUM |
| Fondaparinux Sodium | FONDAPARINUX SODIUM | Sandoz Inc. | baa50757-a927-4d56-a933-5d7798fe6ab0 | 2025-08-27 | Boxed warning, Warnings, Adverse reactions | Fondaparinux Sodium FONDAPARINUX SODIUM |
| Arixtra | FONDAPARINUX SODIUM | Mylan Institutional LLC | d3b30c68-cf45-4b46-8ba6-72090f7ba01a | 2024-12-10 | Boxed warning, Warnings, Adverse reactions | FONDAPARINUX SODIUM |
| FONDAPARINUX SODIUM | FONDAPARINUX SODIUM | Eugia US LLC | 8ea61d0d-4403-4d9f-a946-85a459cc0aa0 | 2024-01-10 | Boxed warning, Warnings, Adverse reactions | FONDAPARINUX SODIUM FONDAPARINUX SODIUM |
| Fondaparinux Sodium | FONDAPARINUX SODIUM | Dr. Reddy's Laboratories Limited | 49e0d7bc-3f49-849b-c77c-98682d1c0d19 | 2021-09-10 | Boxed warning, Warnings, Adverse reactions | Fondaparinux Sodium FONDAPARINUX SODIUM |
| fondaparinux sodium | FONDAPARINUX SODIUM | Italfarmaco S.p.A | 58789e3d-e5bc-4c2e-a527-495a252fcecd | 2020-10-30 | Boxed warning, Warnings, Adverse reactions | fondaparinux sodium FONDAPARINUX SODIUM |
| Fondaparinux Sodium | FONDAPARINUX SODIUM | Mylan Institutional LLC | 4b65f642-87f7-4da5-a9c9-02cd1f8d9d16 | 2020-08-15 | Boxed warning, Warnings, Adverse reactions | Fondaparinux Sodium FONDAPARINUX SODIUM |